Subacute sclerosing panencephalitis: Fulminant form;Panencefalitis esclerosante subaguda: Forma fulminante

Revista de Neurologia

Volumn 36, Issue 6, 2003, Pages 536-539

  Grippo, Jorge ^a,e   Caceres L ^b   Asis A ^d   Grippo, T ^c   Ruprecht, B ^a   Lopez M ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^c UNIVERSIDAD AUSTRAL   (Argentina)

^d Hospital R Carrillo   (Argentina)

^e LM Campos   (Argentina)

Author keywords

Fulminant form; Inmunization; MRI; Refractory myoclonic jerks; Subacute sclerosing panencephalitis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES VACCINE;

ANTIBODY TITER; ARTICLE; ATAXIA; CASE REPORT; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; LANGUAGE DISABILITY; MALE; MEASLES; MEASLES VACCINATION; NEUROLOGICAL COMPLICATION; PRESCHOOL CHILD; SEIZURE; SUBACUTE SCLEROSING PANENCEPHALITIS; VACCINATION; VIRUS INFECTION;

EID: 0037448832     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3606.2002179     Document Type: Article

References (35)

1. Hersh BS, Tambini G, Nogueira AC, Carrasco P, De Quadros CA. Review of regional measles surveillance data in the Americas, 1996-99. Lancet 2000; 355: 1943-8.
2. Dyken PR, Cunningham SC, Ward LC. Changing character of subacute sclerosing panencephalitis in the United States. Pediatr Neurology 1989; 5: 339-41.
3. Ross KL. Viral infection. In Goetz CG, Pappert EJ, eds. Textbook of clinical neurology. Philadelphia: WB Saunders; 1999. p. 828-9.
4. Dlugos DJ. Resurgence of subacute sclerosing panencephalitis in Philadelphia in 1995. Ann Neurol 1996; 40: 311.
5. Risk WS, Kaddad FS. The variable natural history of subacute sclerosing panencephalitis: a study of 118 cases from Middle East. Arch Neurol 1979; 36: 610-4.
6. Dyken PR. Subacute sclerosing panencephalitis. Neurol Clin 1985; 3: 179-95.
7. Dyken PR. Neuroprogressive disease of post-infectious origin: a review of a resurging subacute sclerosing panencephalitis (SSPE). Ment Retard Dev Disabil Res Rev 2001; 7: 217-25.
8. Taratuto AL, Grippo J, Chamoles N. La inclusión viral en la panencefalitis subaguda esclerosante. Medicina (Buenos Aires) 1976; 36: 207-11.
9. Billeter MA, Cattaneo R, Spielhofer P. Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis. Ann N Y Acad Sci 1994; 724: 367-77.
10. Assad F, Gispen F, Kleemola M. Neurological diseases associated with viral and Mycoplasma pneumoniae infections. Bull WHO 1980; 58: 297-311.
11. MC Carthy VP, Zimmerman AW, Miller CA. Central nervous system manifestations of parainfluenza virus type 3 infections on childhood. Pediatr Neurol 1990; 6: 197-201.
12. Barans TZ, González-Gómez I, De X, Yao D, Gilles F, Nelson J, et al. Subacute sclerosing panencephalitis in an infant: diagnostic role of viral genome analysis. Ann Neurol 1994; 36: 103-8.
13. Budka M, Urbanits S, Liberski PP, Eichinger S, Popow-Kraupp T. Subacute measles virus encephalitis: a new and fatal opportunistic infection in a patient with AIDS. Neurology 1996; 46: 586-7.
14. Anlar B, Kose G, Gurer Y, Altunbasak S, Haspolat S, Okan N. Changing epidemiological features of subacute sclerosing panencephalitis. Infection 2001; 29: 192-5.
15. Takayama S, Iwasaki Y, Yamanouchi H. Characteristic clinical feature in a case of fulminant subacute sclerosing panencephalitis. Case report. Brain Dev 1994; 16: 132-5.
16. Markand ON, Panszi JG. The electroencephalogram in subacute sclerosing paencephalitis. Arch Neurol 1975; 32: 719-26.
17. Jabbour JT, Garcia JH, Lemmi H, Ragland J, Duenas DA, Sever JL. SSPE: a multidisciplinary study of eight cases. JAMA 1969; 207: 2248-54.
18. Lum GB, Wiliams JP, Dyken PR. Magnetic resonance and CT imaging correlated with clinical status in SSPE. Pediatr Neurol 1986; 2: 75-9.
19. Geller TJ, Vern BA, Sarwar M. Focal MRI findings in early SSPE. Pediatric Neurol 1987; 3: 310-2.
20. Anlar B, Saatci I. MRI findings in subacute sclerosing panencephalitis. Neurol 1996; 47: 1278-83.
21. Hayashi T, Ichiyama T, Nishikawa M, Furukawa S. Carbamazepine and myoclonus in SSPE, subacute sclerosing panencephalitis. Pediatr Neurol 1996; 14: 346.
22. Panitch HS, Gómez-Plasencia J, Norris FH, Cantell K, Smith RA. Subacute sclerosing panencephalitis: remission after treatment with intraventricular interferon. Neurology 1986; 36: 562-6.
23. Anlar B, Yalaz K, Oktem F, Kose G. Long term follow up of patients with subacute sclerosing panencephalitis treated with intraventricular alfa interferon. Neurology 1997; 48: 526.
24. Anlar B, Yalaz K, Kose G, Saygi S. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis. J Child Neurol 1998.
25. Cianchetti-Marrosu MG, Muntoni F, Fratta A, Zuddas A. Intraventricular alfa interferon in subacute sclerosing panencephalitis. Neurology 1998;50:315.
26. Hosoya M, Shigeta S. High-dose intravenous ribavirin therapy for sub-acute sclerosing panencephalitis. Antimicrob Agents Chemother 2001; 45: 943-5.
27. Takahashi T, Hosoya M. The cooperative effect of interferon and ribavirin on subacute sclerosing panencephalitis virus infections, in vitro and in vivo. Antiviral Res 1998; 37: 29-35.
28. Stephen BT, Ramel AC, Cormae AO. Intraparenchymal alpha interferon and intraventricular ribavirin for subacute sclerosing panencephalitis (SSPE). Neurology 2000; 54: A430.
29. Tomoda A, Shiraishi S, Hosoya M, Mike T. Combination treatment with interferon alfa and ribavirin for sclerosing panencephalitis. Pediatr Neurol 2001; 24: 54-9.
30. Haspolat S, Anlar B, Kose G, Coskun M, Yegin O. Interleukin-1-beta, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols. J Child Neurol 2001; 16: 417-20.
31. Yalaz K, Anlar B, Oktam F. Intraventricular interferon and oral inosiplex. Neurol 1992; 42: 488-91.
32. Gokcil Z, Odabasi Z, Demirkaya S, Eroglu E, Vural O. Alpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis. J Neurol Sci 1999; 162: 62-4.
33. Anlar B, Gucuyener K. Cimetidine as an immunomodulator in subacute sclerosing panencephalitis: a double blind, placebo-controlled study. Pediatr Infect Dis J 1993; 12: 578-81.
34. Hara T, Yamashita S, Aiba H, Nihei K, Koide N, Good RA, et al. Measles viras-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol 2000; 6: 121-6.
35. Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J 2002; 78: 63-70.